4FJY | pdb_00004fjy

Crystal structure of PI3K-gamma in complex with quinoline-indoline inhibitor 24f


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.90 Å
  • R-Value Free: 
    0.275 (Depositor) 
  • R-Value Work: 
    0.197 (Depositor) 
  • R-Value Observed: 
    0.203 (Depositor) 

wwPDB Validation 3D Report Full Report

Validation slider image for 4FJY

Ligand Structure Quality Assessment 


This is version 1.1 of the entry. See complete history

Literature

Discovery and in Vivo Evaluation of Dual PI3K-beta/delta inhibitors

Gonzalez-Lopez de Turiso, F.Shin, Y.Brown, M.Cardozo, M.Chen, Y.Fong, D.Hao, X.He, X.Henne, K.Hu, Y.L.Johnson, M.G.Kohn, T.Lohman, J.McBride, H.J.McGee, L.R.Medina, J.C.Metz, D.Miner, K.Mohn, D.Pattaropong, V.Seganish, J.Simard, J.L.Wannberg, S.Whittington, D.A.Yu, G.Cushing, T.D.

(2012) J Med Chem 55: 7667-7685

  • DOI: https://doi.org/10.1021/jm300679u
  • Primary Citation Related Structures: 
    4FJY, 4FJZ

  • PubMed Abstract: 

    Structure-based rational design led to the synthesis of a novel series of potent PI3K inhibitors. The optimized pyrrolopyridine analogue 63 was a potent and selective PI3Kβ/δ dual inhibitor that displayed suitable physicochemical properties and pharmacokinetic profile for animal studies. Analogue 63 was found to be efficacious in animal models of inflammation including a keyhole limpet hemocyanin (KLH) study and a collagen-induced arthritis (CIA) disease model of rheumatoid arthritis. These studies highlight the potential therapeutic value of inhibiting both the PI3Kβ and δ isoforms in the treatment of a number of inflammatory diseases.


  • Organizational Affiliation
    • Department of Therapeutic Discovery, Amgen Inc., 1120 Veterans Boulevard, South San Francisco, California 94080, USA. felgonza@amgen.com

Macromolecule Content 

  • Total Structure Weight: 110.58 kDa 
  • Atom Count: 6,858 
  • Modeled Residue Count: 839 
  • Deposited Residue Count: 960 
  • Unique protein chains: 1

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform960Homo sapiensMutation(s): 0 
Gene Names: PIK3CG
EC: 2.7.1.153 (PDB Primary Data), 2.7.11.1 (PDB Primary Data), 2.7.1.137 (UniProt), 2.7.1.154 (UniProt)
UniProt & NIH Common Fund Data Resources
Find proteins for P48736 (Homo sapiens)
Explore P48736 
Go to UniProtKB:  P48736
PHAROS:  P48736
GTEx:  ENSG00000105851 
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupP48736
Sequence Annotations
Expand
Reference Sequence

Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.90 Å
  • R-Value Free:  0.275 (Depositor) 
  • R-Value Work:  0.197 (Depositor) 
  • R-Value Observed: 0.203 (Depositor) 
Space Group: C 1 2 1
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 144.223α = 90
b = 67.711β = 95.08
c = 106.772γ = 90
Software Package:
Software NamePurpose
SCALEPACKdata scaling
REFMACrefinement
PDB_EXTRACTdata extraction
CrystalCleardata collection
DENZOdata reduction
REFMACphasing

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 


Entry History 

Deposition Data

Revision History  (Full details and data files)

  • Version 1.0: 2012-10-24
    Type: Initial release
  • Version 1.1: 2024-02-28
    Changes: Data collection, Database references, Derived calculations